Automation and digitalization
Automation and digitalization
Revolutionary Atlas System Transforms Bioprocessing Analysis
🔍 Nirrin Technologies launches Atlas system for at-line analysis in bioprocessing applications, revolutionizing analytical workflow. 🌐💡🔬📈🌟
Revolutionizing Bioprocessing: Faster Easier Cost-efficient Analysis
🔍 Bioprocessing analytics tools are complex, but developers aim to make them accessible for bioprocess scientists. 🧪💰 908 Devices' Rebel device cuts analysis time from weeks to 12 minutes. ⏱️💉 Industry collaboration and regulatory support drive biomanufacturing innovation.
Cellular Origins Acquires ACTIA Platform IP Revolutionizing Cell Therapy Manufacturing
1. 📣 Exciting news! Cellular Origins acquires ACTIA Platform IP for cell therapy manufacturing, revolutionizing the industry! 🧪 2. 🚀 Accelerate your cell therapy manufacturing with Cellular Origins' robotic solution, Constellation™. The future is here! 3. 💡 Introducing Constellation™ - the scalable system that integrates automation robotics and aseptic fluid-handling technologies. 4. 👩🔬 Breakthrough acquisition! Cellular Origins solves the challenge of large-scale cell therapy production with ACTIA Platform.
Breakthrough Partnership Boosts Drug Industry Data Alignment
🔍 Biopharma's drug quality efforts hindered by lack of data uniformity in supply chain. NIIMBL and OAGi team up to help. 🤝💡💊🌐💼💡⚙️📚🌍
Revolutionizing mRNA Manufacturing: How Automation Solves Challenges
🔍 Addressing mRNA Manufacturing's Biggest Challenges Using Automation. 💪 Automation improves efficiency, scalability, and response time. 🤖⚡️🌍 It also enhances data management and regulatory compliance. 🔐🏭✨
Revolutionizing Biopharmaceutical Manufacturing: The Smart Way
📅 June 18, 2024: Biopharmaceutical manufacturing transitions to smart operations, utilizing data analytics, technology, and continuous manufacturing. 🧪💡📊
Tech Unlocks Sustainable Biopharma Revolution
🌍 A study by Imperial College London suggests that digital tools can help companies understand their environmental impact. 💡 Process sustainability can be challenging to quantify, but model-based tools exist to tackle case studies. 💧 Water consumption in cell cultivation and the use of resins and solvents are major sustainability challenges. ⚙️ Continuous manufacturing and automation are seen as sustainable approaches that can lower costs and environmental impact. 📚 However, technical and regulatory challenges need to be addressed for widespread adoption of these practices.
Unlocking Advanced Therapy’s Potential with AI: The Key Ingredients
🌍 Advanced therapy manufacturers must have robust hardware and monitoring software in place before benefiting from AI. 🤖📈
Revolutionizing Drug Manufacturing with Data Analysis
💊🔬 Rethinking Data in Drug Manufacturing: The FoReSight framework transforms raw data into actionable information for decision-making. 🧪📊💡📚
Revolutionizing Cell Therapy: Likarda and Cold Chain Technologies Join Forces
🚚🧪 Likarda and Cold Chain Technologies join forces to revolutionize cell therapy manufacturing with advanced logistics solutions.
